Head For The Cure is trilled to once again partner with Novocure as a 2016 National Sponsor. Novocure has helped to enrich our events by having a local presence at each 5k to share the inner workings of their brand.
Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. Headquartered in Jersey Isle, Novocure’s US operations are based in Portsmouth, NH and New York, NY. Additionally, the company has offices in Switzerland, Germany and Japan and a research center in Haifa, Israel.
Tumor Treating Fields, or TTFields, were discovered by Novocure founder, Yoram Palti, MD, PhD, a specialist in electrophysiology and biophysics. Dr. Palti began to explore the potential of electrical fields as a cancer treatment in the late 1990s and, once satisfied with his hypothesis on paper, headed to the basement of his home to set up a laboratory in 2000. A company was born. The original Novocure team comprised of three employees, a biologist, an engineer and a technician, two of whom are still with the company today.